NorthWest Biotherapeutics Inc (NWBO)

[blue_skies]

That's not how trials work. If the treatment worked per the DMC during the IA, the DMC would have recommended the trial be halted for efficacy, the company would have unblinded and submitted a BLA (back in 2016).

That my understanding of how it works. Procedurally this brings, new, promising treatments to patients faster. A win for the companies, and a win for the patients. 5+ years later no TLD.

I am not saying that DCVAX L does not work. But it is tragic that this treatment is not now available.